Histopathological aspects described in patients with chronic hepatitis c

... doi:10.1186/1743-422X-7-311 Cite this article as: Scagnolari et al.: Differential expression of interferoninduced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon ... http://www.virologyj.com/content/7/1/311 Page of Table Baseline expression of microRNAs and MxA-mRNA in healthy controls and in patients with chronic hepatitis C (CHC) Healthy controls* n = 10 Patients with CHC* ... MA, Carreño V: In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus J Infect Dis 1999, 180:262-267 Erickson...

... biopsy for the first line assessment of liver injury in patients with chronic hepatitis C In clinical practice, liver biopsy should be recommended only as a second line test, i.e., in case of high ... carried out biochemical analyses RP, DT, VR, and YB participated in the coordination of the study, and drafted the manuscript AM participated in the design and coordination of assays in the control ... Knodell and Ishak necroinflammatory activity scoring systems (lower panel) the diagnostic values of FT-AT was summarized using the cutoffs of the distribution by stages and grades (Tables and 4) The...

... is of little utility as a diagnostic tool because a high percentage of patients with chronic HCV infection display serum RF reactivity, and the frequency of RF increases in patients with articular ... Available online http:/ /arthritis- research.com/content/6/2/R137 Table Table Clinical and demographic characteristics of patients with RA Clinical and demographic characteristics of patients with HCV RA ... possible utility of anti-CCP antibodies in differentiating RA from HCV-related arthropathy The aim of this study was to evaluate, in a cohort of consecutive patients with chronic HCV infection, whether...

... coinfection is associated with increased mortality [13]) and (e) alive on the index date, defined as year after the date of the HCV RNA test The study included all DANVIR participants fulfilling ... 2) Alcohol abuse and HIV infection Information on alcohol abuse and HIV infection was obtained from DNPR (see Appendix for details) Injection drug use To be characterized as having IDU a patient ... HCV-infection was associated with mortality in patients both with and without pre-existing liver diseases, which indicates that severity of liver disease did not explain our findings Our analyses...

... CVD, malnutrion and inflammation in ESRD patients (25, 26) Hypoalbuminemia, a marker of malnutrition and underlying inflammation has come up as a powerful predictor of mortality in patients with ... C Inflammation enhances cardiovascular risk and mortality in hemodialysis patients Kidney Int 1999; 55: 64 8-6 58 27 Foley RN, Parfrey PS, Harnett JD, et al Hypoalbuminemia, cardiac morbidity, and ... of uremia: oxidative stress as a unifying concept of cardiovascular disease in uremia Kidney Int 2002; 62: 152 4-1 538 47 Stenvinkel P, Alvestrand A Inflammation in end-stage renal disease: sources,...

... article as: Cappuzzello et al.: Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-g in patients with chronic heart failure Journal of Translational Medicine 2011 9:28 ... increase was observed (data not shown) In conclusion, the novelty in our study results is the increase of IL-9 and decrease of IL-5, IL-7, and IFN-g plasma levels, in both ICM and NIDCM CHF patients ... correlated IL-5, IL-7, IL-9 and IFN-g plasma levels with the patients echocardiographic parameters, such as LVEF and LVIDd, and with disease duration Interestingly, in ICM patients, IL-9 levels inversely...

... this article as: Ido et al.: Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical ... Sakiyama O, Takahashi K, Kimoto M, Kawasaki S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases ... and partial characterization of hepatocyte growth factor from plasma of patients with fulminant hepatic failure J Clin Invest 1988, 81:414-419 10 Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta...

... 0.5.[23] Using the regression equation and the minimal important difference of the anchors (0.5 points for the CRQ[15] and points for the FT[23]) we estimated the minimal important difference of the ... sizes of trials and to make treatment decisions without the understanding that the point estimate of 1.5 is the best estimate of the minimal important difference and that the limits of the CIs ... linear regression analysis where the instrument of interest is the dependent and the anchors the independent variable Using the equation one can estimate the minimal important difference of the...

... and subjective health status [3] An important issue in understanding the complexity of COPD as an illness and thereby its management, is what determines the subjective health status of these patients ... knowledge about what determines subjective health status in this group of patients is relevant for the treatment of COPD, and for the care and rehabilitation of patients To this end, the aim of the present ... and subjective health status, but lack a multivariate perspective on subjective health status in COPD According to the biopsychosocial perspective, subjective health status cannot be explained...

... article as: Cappuzzello et al.: Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-g in patients with chronic heart failure Journal of Translational Medicine 2011 9:28 ... increase was observed (data not shown) In conclusion, the novelty in our study results is the increase of IL-9 and decrease of IL-5, IL-7, and IFN-g plasma levels, in both ICM and NIDCM CHF patients ... correlated IL-5, IL-7, IL-9 and IFN-g plasma levels with the patients echocardiographic parameters, such as LVEF and LVIDd, and with disease duration Interestingly, in ICM patients, IL-9 levels inversely...

... arms in terms of the HRQOL scores at base line (data not shown) Table 2: Baseline SF-36 norm based Domain scores in refractory HCV patients undergoing re-treatment with peg interferon alpha 2b and ... HRQOL domain scores when re-treated with a combination of interferon alpha- 2b and ribavirin Compared to the baseline, the responders sustained a significant decrease in the domain score of vitality ... health-related quality of life in HCV and improvement with interferon therapy Hepatology 1999, 29:264-270 Carithers RL Jr, Emerson SS: Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials...

... used patients with "average disease severity" as the reference group For continuous variables, such as age in years or scale scores, the odds ratio for a particular category, as well as for between-category ... the patient's and the physician's views of disease severity as part of a longitudinal study of HRQoL in a large cohort of patients with chronic cardiac or pulmonary disease Using these data, in ... myocardial infarction was the single strongest predictor of the patient actually having an infarction [37] Other investigators found that in predicting return to work in patients with coronary disease, ...

... the aim of comparing their performance in evaluating pain exacerbations in terms of reproducibility and of discriminatory capability to distinguish pain exacerbations over a background of less ... between VRS and NRS scores (as for example: corresponding to "None", 1-4 to "Mild pain" , 5-6 to "Moderate pain" , and 7-10 to severe pain1 [14,27-29]), should be interpreted cautiously in clinical ... V: Pain measurement in cancer patients: a comparison of six methods Pain 1994, 57(2):161-166 14 Briggs M, Closs JS: A descriptive study of the use of visual analogue scales and verbal rating scales...